Thus, although the exact mechanism of action of Wee1 in SCLC therapeutic resistance has not been conclusively established, given the direct association of SCLC therapeutic resistance with cell cycle arrest due to DNA damage, the regulation of SCLC drug resistance by Wee1 through cell cycle checkpoints is currently considered as the classical pathway for its action. This evidence concerns the gene WEE1 and small cell lung carcinoma.